Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/1996
10/09/1996CN1133041A New compound and its prep.
10/09/1996CN1133035A Substituted pyridine-2-ones and substituted pyridine-2-thiones as biocides
10/09/1996CN1133013A Vaccin respiratory syncytial viral vaccines
10/09/1996CN1132756A Antiviral ethers of aspartate protease substrate isosteres
10/09/1996CN1132752A Beta-lactams derivative and its prep. and use
10/08/1996US5563265 Bactericides
10/08/1996US5563145 Rapamycin 42-oximes and hydroxylamines
10/08/1996US5563143 Antiinflammatory agents, autoimmune disorders
10/08/1996US5563138 Benzoheterocyclic compounds
10/08/1996US5563135 Immunosuppressive agent
10/08/1996US5563125 5'-deoxy-5'-(substituted)alkylthioribose compounds and their pharmaceutical compositions
10/08/1996US5563123 Chimeric proteins
10/08/1996US5563120 Cytokine preparation for immunotherapy
10/08/1996US5563050 Herpes virus
10/08/1996US5563049 Culture product
10/08/1996US5563048 Human stromal derived factor 1α and 1β, and DNAs encoding the same
10/08/1996US5562903 Humanized antibodies that recognize difucosyl Lewis blood group antigens Y-6 and B-7-2
10/08/1996CA2010768C Acidic polycyclic ether antibiotic
10/08/1996CA1338632C Cloning and sequencing of the gene which codes for a new pilinic subunit of bordetella pertussis
10/03/1996WO1996030544A1 Diagnostic and therapeutic system for crohn's disease and colitia ulcerosa
10/03/1996WO1996030533A1 Pseudotyped retroviral particles
10/03/1996WO1996030520A2 Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein
10/03/1996WO1996030519A1 Haemophilus adhesion proteins
10/03/1996WO1996030512A1 Conditional expression system
10/03/1996WO1996030401A1 Glycopeptide antibiotic derivatives
10/03/1996WO1996030399A1 Cyclic peptide nuclei and derivatives thereof
10/03/1996WO1996030387A1 Novel human cytomegalovirus dna sequences
10/03/1996WO1996030377A1 Nitrogenous macrocyclic compounds
10/03/1996WO1996030343A1 Inhibitors of farnesyl-protein transferase
10/03/1996WO1996030056A1 Hydroxyalkyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same
10/03/1996WO1996030053A1 Methods of screening compounds useful for prevention of infection or pathogenicity
10/03/1996WO1996030043A1 Treatment for verotoxin-producing escherichia coli
10/03/1996WO1996030039A1 Method for enhancing the antibody response to specific antigens with interleukin-10
10/03/1996WO1996030033A1 Method of treating or preventing non-viral microbial infection
10/03/1996WO1996030025A1 Synergistic combinations of zidovudine, 1592u89 and 3tc or ftc
10/03/1996WO1996013498A3 L-erythrosyl nucleosides
10/03/1996WO1994004702A3 Improved detection and therapy of lesions with biotin/avidin conjugates
10/03/1996CA2218601A1 Treatment for verotoxin-producing escherichia coli
10/03/1996CA2216807A1 Diagnostic and therapeutic system for crohn's disease and colitia ulcerosa
10/03/1996CA2216707A1 Inhibitors of farnesyl-protein transferase
10/03/1996CA2216292A1 Haemophilus adhesion proteins
10/03/1996CA2215968A1 Method for enhancing the antibody response to specific antigens with interleukin-10
10/03/1996CA2215836A1 Methods of screening compounds useful for prevention of infection or pathogenicity
10/03/1996CA2215833A1 Hydroxyalkyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same
10/03/1996CA2214464A1 Method of treating or preventing non-viral microbial infection
10/03/1996CA2214451A1 Conditional expression system
10/02/1996EP0735045A1 Process for the preparation of 2,2'-andhydro- and 2'-keto-1-(3',5'-di-o-protected-beta -d-arabinofuranosyl) nucleosides
10/02/1996EP0735044A1 Preparation of D4T from 5-methyluridine
10/02/1996EP0735041A1 New compounds of the secomacrolide and secoazalide class and a process for the preparation thereof
10/02/1996EP0735031A1 N-acetylpiperazine derivative, antibacterial drug, and anti-ulcer drug
10/02/1996EP0735019A2 Retroviral protease inhibitors
10/02/1996EP0734529A1 Methods and materials for the detection of staphylococcus aureus
10/02/1996EP0734439A1 p53-BINDING POLYPEPTIDES AND POLYNUCLEOTIDES ENCODING SAME
10/02/1996EP0734391A1 Pna-dna-pna chimeric macromolecules
10/02/1996EP0734387A1 Hiv protease inhibitors
10/02/1996EP0734382A1 Crystalline n-acetyl neuraminic acid derivatives and processes for their preparation
10/02/1996EP0734251A1 Method of transmitting a biologically active material to a cell
10/02/1996EP0734249A1 Novel and improved aminoglycoside formulation for aerosolization
10/02/1996EP0575497B1 Dna sequences which code for virulence characteristics of -$(streptococcus suis) and parts thereof, polypeptides and antibodies derived therefrom and the use thereof for the diagnosis of and protection against infection by -$(s. suis) in mammals, including man
10/02/1996EP0471794B1 Antiviral therapy using thiazine and xanthene dyes
10/02/1996DE19513040A1 Neue Borneolester, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung New Borneo Lester, processes for their preparation and their pharmaceutical use
10/02/1996CN1132516A Monoclonal IgA antibody against respiratory syncytial virus
10/02/1996CN1132479A Mycophenolate mofetil high dose oral suspensions
10/02/1996CN1132467A Substantive antimicrobial phosphates
10/02/1996CN1132210A Cyclohexapeptides and their mixtures, process for preparing them, and their use
10/02/1996CN1132073A 1,3-oxathiolane nucleoside analogues
10/01/1996US5561146 Modified guanidino and amidino thrombin inhibitors
10/01/1996US5561118 Antibiotics
10/01/1996US5561108 Preparation of α1 -antichymotrypsin
10/01/1996US5561060 Having pharmacological applicability
10/01/1996US5561043 Genetic engineering
10/01/1996US5560816 Method for electrolyzing fluids
10/01/1996CA2172913A1 N-acylpiperazine derivative, antibacterial drug, and anti-ulcer drug
09/1996
09/26/1996WO1996029604A1 Method for diagnosing a patient for chlamydia
09/26/1996WO1996029425A1 Hormone and growth factor phosphoglycan mimetics from mycobacterium vaccae
09/26/1996WO1996029421A1 Vectors for gene delivery
09/26/1996WO1996029413A2 Dna encoding human papilloma virus type 18
09/26/1996WO1996029412A1 Proteinase k resistant surface protein of neisseria meningitidis
09/26/1996WO1996029407A2 Cellubrevin homologs
09/26/1996WO1996029396A1 Recombinant infectious laryngotracheitis virus and uses thereof
09/26/1996WO1996029339A1 Fucopeptides
09/26/1996WO1996029337A1 Thiono triester modified antisense oligodeoxynucleotide phosphorothioates
09/26/1996WO1996029336A1 Chemical compounds
09/26/1996WO1996029333A1 Substituted tetronic acids useful for treating hiv and other retroviruses
09/26/1996WO1996029313A1 Lactam-containing hydroxamic acid derivatives, their preparation and their use as inhibitors of matrix metalloprotease
09/26/1996WO1996029091A1 Treatment of papillomavirus-associated lesions using interleukin-12
09/26/1996WO1996029083A1 Epithelial adhesive lactobacilli
09/26/1996WO1996029080A1 Poly(hydroxy acid)/polymer conjugates for skin applications
09/26/1996WO1996029077A1 Use of thiazepine, oxazepine and diazepine coumpounds for inhibiting hiv, herpesvirus and suppressing the immune system
09/26/1996WO1996029056A1 Topically applied pharmaceutical composition, method of preparing it and its use
09/26/1996WO1996028975A1 Topical antimicrobial agents
09/26/1996WO1996024364A3 Antimicrobial composition composed of controlled release glasses
09/26/1996WO1996021014A3 Production and administration of high titer recombinant retroviruses
09/26/1996WO1996011272A3 Papilloma virus-like particles, fusion proteins and process for producing the same
09/26/1996CA2216284A1 Thiono triester modified antisense oligodeoxynucleotide phosphorothioates
09/26/1996CA2216147A1 Cellubrevin homologs
09/26/1996CA2216139A1 Recombinant infectious laryngotracheitis virus and uses thereof
09/26/1996CA2215525A1 Treatment of papillomavirus-associated lesions using interleukin-12
09/26/1996CA2215162A1 Vectors for gene delivery
09/26/1996CA2214107A1 Fucopeptides
1 ... 1603 1604 1605 1606 1607 1608 1609 1610 1611 1612 1613 1614 1615 1616 1617 1618 1619 1620 1621 1622 1623 ... 1798